[ad_1]
The US will approve the BioNTech and Pfizer coronavirus vaccine for use in the next 12 to 15 years, depending on the people involved in the regulatory process.
Pharmaceutical companies applied for permission begin to insert adolescents in the last month, after trials suggested, inoculations were 100 percent effective in preventing symptomatic diseases among the elderly.
Two people close to the process said the Food and Drug Administration hoped to give the green light next week, a move that could help bring the U.S. closer to “herd immunity” and a move that could be essential to reopening schools full time in the fall.
The FDA and Pfizer refused.
BioNTech / Pfizer vaccine accepted for 16-year-olds, it was administered 131 million times last year, according to data from the U.S. Centers for Disease Control and Prevention. This allows the U.S. to inject more than 50 percent of the adult population with a single dose, making it one of the largest Covid-19 inoculation campaigns in the world.
The vaccine report has helped reduce U.S. cases and deaths in recent weeks. According to latest data Collected by the Financial Times, the country reports about 50,000 cases a day and about 700 deaths, roughly the rates it had in October last year.
Scientists have said that to gain immunity from the herd – When they have antibodies that the virus can no longer spread. However, the U.S. should include more than three-quarters of the population. That would be difficult if the children didn’t get vaccinated too.
In March, Pfizer announced the results of Phase 3 clinical trials in 12-15 year olds better results Than for 16-25 year olds. Of the 2,260 teens who participated in the trial, 18 were infected with Covid-19, all in the placebo group.
The FDA, which approves all U.S. drugs, should not issue new permits to use the Pfizer vaccine in children under 16, avoiding the need for lengthy consultation with outside experts.
However, the CDC, which provides public health guidance, will consult with some outside scientists before making its recommendations. The jury told children between the ages of 12 and 15 that they expect a meeting to discuss vaccination with the Pfizer jab, according to a person familiar with the plans.
Anthony Fauci, head of the U.S. National Institute of Allergy and Infectious Diseases, said earlier that he hoped high school children would start getting vaccinated in the fall and younger children next year.
[ad_2]
Source link
